Meinian Onehealth Healthcare Holdings Co., Ltd. cancelled the acquisition of 69.86% stake in Nanning Meiyuan Health Management Co., Ltd. from Chen Xiaoping and Shaoxing Kemai Life and Health Industry Equity Investment Partnership Enterprise (L.P.).
Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) agreed to acquire 69.86% stake in Nanning Meiyuan Health Management Co., Ltd. from Chen Xiaoping and Shaoxing Kemai Life and Health Industry Equity Investment Partnership Enterprise (L.P.) on April 15, 2025. The consideration consists of common equity of Meinian Onehealth Healthcare Holdings Co., Ltd. to be issued for common equity of Nanning Meiyuan Health Management Co., Ltd. As part of consideration, an undisclosed value is paid towards common equity of Nanning Meiyuan Health Management Co., Ltd.
For the period ending December 31, 2024, Nanning Meiyuan Health Management Co., Ltd. reported total revenue of CNY 17.41 million and net income of CNY 1.8 million. As of December 31, 2024, Nanning Meiyuan Health Management Co., Ltd. reported total assets of CNY 21.45 million and total common equity of CNY 6.24 million.
The transaction is subject to Meinian Onehealth?s directorate?s further approval after completion of audit and valuation, approval by seller?s internal decision-making bodies, approval by Meinian Onehealth Healthcare?s shareholders? meeting, subject to approval by Shenzhen Stock Exchange and China Securities Regulatory Commission and subject to any other approval as may be required by the law. The deal has been approved by the board of Meinian Onehealth Healthcare Holdings.
Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) cancelled the acquisition of 69.86% stake in Nanning Meiyuan Health Management Co., Ltd. from Chen Xiaoping and Shaoxing Kemai Life and Health Industry Equity Investment Partnership Enterprise (L.P.) in July, 2025.
Meinian Onehealth Healthcare Holdings Co, Ltd. specialises in the provision of healthcare services to businesses and individuals. Net sales break down by activity is as follows:
- professional medical examination services (96.7%): routine medical examination services, medical consultations, medical monitoring, etc.;
- other (3.3%).
At the end of 2021, the Group operates 613 medical examination centers in China.
All sales are made in China.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
-
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
-
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Meinian Onehealth Healthcare Holdings Co., Ltd. cancelled the acquisition of 69.86% stake in Nanning Meiyuan Health Management Co., Ltd. from Chen Xiaoping and Shaoxing Kemai Life and Health Industry Equity Investment Partnership Enterprise (L.P.).
